Paper16896992
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O and 3 others. Int J Colorectal Dis, 2007. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Papers, record 16896992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16896992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Matrix Metalloproteinase 14 | Major topic |
| Matrix Metalloproteinase 2 | Major topic |
| Matrix Metalloproteinase 7 | Major topic |
| Rectal Neoplasms | Major topic |
| Tissue Inhibitor of Metalloproteinase-2 | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| Predictive Value of Tests | |
| Survival Analysis |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15239346 | Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma. | Pathol Res Pract | 2004 | https://conductscience.org/library/papers/15239346 | PubMed |
| 2 | 1646457 | Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. | Mod Pathol | 1991 | https://conductscience.org/library/papers/1646457 | PubMed |
| 3 | 8008747 | Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. | Mod Pathol | 1994 | https://conductscience.org/library/papers/8008747 | PubMed |
| 4 | 9310250 | Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9310250 | PubMed |
| 5 | 11355941 | Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11355941 | PubMed |
| 6 | 10485622 | Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. | J Korean Med Sci | 1999 | https://conductscience.org/library/papers/10485622 | PubMed |
| 7 | 10344676 | Impact of surgeon's technique on outcome after treatment of rectal carcinoma. | Dis Colon Rectum | 1999 | https://conductscience.org/library/papers/10344676 | PubMed |
| 8 | 7661515 | Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. | Ann Otol Rhinol Laryngol | 1995 | https://conductscience.org/library/papers/7661515 | PubMed |
| 9 | 9740080 | Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. | Cancer | 1998 | https://conductscience.org/library/papers/9740080 | PubMed |
| 10 | 11494227 | Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11494227 | PubMed |
| 11 | 15103490 | Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. | Int J Colorectal Dis | 2004 | https://conductscience.org/library/papers/15103490 | PubMed |
| 12 | 10403738 | Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. | Gut | 1999 | https://conductscience.org/library/papers/10403738 | PubMed |
| 13 | 8895669 | Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. | Jpn J Clin Oncol | 1996 | https://conductscience.org/library/papers/8895669 | PubMed |
| 14 | 10224222 | Regulation of matrix metalloproteinase expression in tumor invasion. | FASEB J | 1999 | https://conductscience.org/library/papers/10224222 | PubMed |
| 15 | 15592677 | Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. | Int J Colorectal Dis | 2005 | https://conductscience.org/library/papers/15592677 | PubMed |
| 16 | 9440760 | Influence of surgery on metachronous distant metastases and survival in rectal cancer. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9440760 | PubMed |
| 17 | 15918187 | Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/15918187 | PubMed |
| 18 | 10901373 | Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10901373 | PubMed |
| 19 | 10328170 | Actual standards and controversies on operative technique and lymph-node dissection in colorectal cancer. | Langenbecks Arch Surg | 1999 | https://conductscience.org/library/papers/10328170 | PubMed |
| 20 | 8918435 | Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. | Dis Colon Rectum | 1996 | https://conductscience.org/library/papers/8918435 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29201696 | Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer. | Euroasian J Hepatogastroenterol | 2015 | https://conductscience.org/library/papers/29201696 | PubMed |
| 26807187 | Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma. | Am J Transl Res | 2015 | https://conductscience.org/library/papers/26807187 | PubMed |
| 26064217 | Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26064217 | PubMed |
| 24395652 | Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24395652 | PubMed |
| 24025354 | Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer. | Cancer Biol Ther | 2013 | https://conductscience.org/library/papers/24025354 | PubMed |
| 23681802 | Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23681802 | PubMed |
| 23184003 | Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis. | Mol Biol Rep | 2013 | https://conductscience.org/library/papers/23184003 | PubMed |
| 21829768 | Matrix metalloproteinase-2 and -7 expression in colorectal cancer. | J Korean Soc Coloproctol | 2011 | https://conductscience.org/library/papers/21829768 | PubMed |
| 19995435 | Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19995435 | PubMed |
| 18925697 | Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer. | Croat Med J | 2008 | https://conductscience.org/library/papers/18925697 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP14 | 4323 | PubTator's text mining | https://conductscience.org/library/genes/4323 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP7 | 4316 | PubTator's text mining | https://conductscience.org/library/genes/4316 | NCBI Gene |
| TIMP2 | 7077 | PubTator's text mining | https://conductscience.org/library/genes/7077 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16896992
GET https://conductscience.org/api/papers/v1/16896992/references?page=2